-

Nomi Health Opening Additional Testing Sites to Serve Community During Omicron Surge

Existing Baltimore Street Clinic COVID-19 Testing Site Has Served the Community Since Mid-December

BALTIMORE--(BUSINESS WIRE)--Nomi Health, the direct healthcare company that has provided COVID-19 testing to the community since mid-December of last year, has proactively opened one additional location and is in the process of opening another, to accommodate the surge in demand for testing as a result of the Omicron variant. New locations include:

Open now: Rehoboth Church Of Deliverance, 603 E Patapsco Ave., Baltimore, MD 21237
Hours of Operation: Monday-Saturday 10AM-2PM

Opening soon: Harbel Community Organization, 5807 Harford Rd., Baltimore, MD 21214
Hours of Operation: Wednesday-Saturday 10AM-5PM

Both PCR and antigen tests are available at the above Nomi Health testing sites. While patients are asked to bring their insurance information, patients without insurance will not be turned away. Patients with questions can call the Nomi Health Call Center at (410) 541-5580. Appointments are not required, but pre-registration is available at http://testing.nomihealth.com/signup/maryland.

The COVID-19 walk-up testing clinic that opened at 419 West Baltimore Street, Baltimore, MD 21201 mid-December last year has surpassed 9,000 tests performed. The highest testing day had 800 tests performed, averaging about 300 per day. The Baltimore Street Clinic site can accommodate up to 1,000 tests per day currently and is fully staffed. The Baltimore Street Clinic testing site offers the fastest COVID-19 test result time in the Baltimore area, providing Rapid PCR (30 minutes for results), Nasal PCR (24-36 hours for results), and Rapid Antigen (30 minutes for results). The hours of operation are currently Monday through Sunday, 8AM - 6PM.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real-time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Contacts

Maggie Habib
mPR, Inc. for Nomi Health
maggie@mpublicrelations.com
310.916.6934

Nomi Health


Release Summary
Nomi Health is opening additional testing sites to serve the Baltimore community during the Omicron surge.
Release Versions

Contacts

Maggie Habib
mPR, Inc. for Nomi Health
maggie@mpublicrelations.com
310.916.6934

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom